🔎 Trials Near Me

Home › Scleroderma › California › Los Angeles

Pag-aaral pangklinika para sa Scleroderma sa Los Angeles, CA

Isang pag-aaral para sa Scleroderma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Los Angeles. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

Nagre-recruitPhase 1/2
  • Nkarta Investigational Site, Los Angeles
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06733935

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

Nagre-recruitPhase 3
  • University of California Los Angeles, Los Angeles
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT07497087

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Nagre-recruitPhase 2/3
  • GSK Investigational Site, Los Angeles
  • GSK Investigational Site, Los Angeles
  • GSK Investigational Site, Los Angeles
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05878717

Platform Clinical Study for Conquering Scleroderma

Nagre-recruitPhase 2
  • Keck School of Medicine at USC Medical Center, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06195072

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Nagre-recruitPhase 2
  • Artiva Investigational Site Los Angeles, Los Angeles
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT06991114

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

Nagre-recruitPhase 1
  • Children's Hospital Los Angeles Division Of Rheumatology, Los Angeles
Edad 12 hanggang 70 · Lahat ng kasarian · Na-update May 22, 2026 · NCT06308978

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

Nagre-recruitPhase 2
  • aTyr Investigative Site, Los Angeles
Edad 18 pataas · Lahat ng kasarian · Na-update May 7, 2025 · NCT05892614

Pag-aaral para sa Scleroderma sa ibang lungsod

Iba pang pag-aaral sa Los Angeles

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.